Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harbor Disruptive Innovation ETF (INNO)

Harbor Disruptive Innovation ETF (INNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

HERZLIYA, Israel and CALGARY, AB , Sept. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

HERZLIYA, Israel and CALGARY, Alberta , Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces Details of Proposed Share Consolidation

HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces First Half Of 2025 Financial Results

HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

HERZLIYA, Israel and CALGARY, AB , Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

HERZLIYA, Israel and CALGARY, Alberta , July 23, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)

Barchart Exclusives

Is This Dividend Stock a Buy Now After Falling Over 11% from Its 2026 Highs?
Citigroup shares are down 11% from their 2026 highs. The stock has a healthy dividend yield of 2.1% and looks like a good buy after the correction. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar